Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

LYPHE GROUP Launches With Portfolio That Will Improve Patient Access to Medical Cannabis

This image opens in the lightbox

News provided by

LYPHE GROUP

08 Oct, 2019, 09:49 GMT

Share this article

Share toX

Share this article

Share toX

Brings together companies at the forefront of innovation in cannabis to provide market leading end to end service for both patients and doctors

LONDON, Oct. 8, 2019 /PRNewswire/ -- LYPHE GROUP launches today, bringing together a portfolio of leading companies in the medical cannabis industry, to transform access to cannabis-based medical products for patients with unmet needs.

The patient-led healthcare provider is building across European markets by providing key infrastructure and vital educational services to patients, doctors and the sector, led by experts in the industry.

Each LYPHE GROUP business shares its central goal: to pioneer patient access to safe and effective medical cannabis treatments.

LYPHE GROUP is comprised of the following industry leading organisations:

  • The Academy of Medical Cannabis – Following its successful launch last November, the online learning platform is training and educating clinicians and healthcare professionals solely on the subject of medical cannabis. The Academy, directed by Professor Mike Barnes, educates to reduce the stigma of this treatment option within the medical community around the world, as well as equipping clinicians with the knowledge to provide patients with expert care. The Academy has a growing presence globally, in locations including UK, Italy, Germany, France, Portugal, Ireland, Brazil and New Zealand.
  • The Medical Cannabis Clinics – The UK's first chain of private clinics specialising in innovative cannabis-based medical therapies and transforming lives by giving patients with unmet medical needs local access to the medical cannabis treatment options they so desperately need. Private clinic chain expert, Richard North continues his leadership of the clinics as Managing Director.
  • Astral Health – The first platform to facilitate the bulk importation of medical cannabis into the UK, with import licenses in place across multiple jurisdictions, and extensive distribution in live markets beyond LYPHE GROUP's ecosystem. Pharmaceutical Executive and Market Access specialist, Robert Whitehouse sits as the Managing Director of Astral Health.
  • Dispensary Green – The UK's first online home-delivery pharmacy for medical cannabis that forms the perfect compliant and seamless link between patients' prescriptions, and fulfilment. Led by Pharmacist superintendent, Chris Ashton as Managing Director.

Through its integrated ecosystem of portfolio companies, LYPHE GROUP is breaking down barriers for patient access to medical cannabis by offering an innovative, standardised and seamless delivery of cannabis medicines and care. Through each of its composite companies, the group is empowering the medical community to prescribe with confidence and deliver the best medical cannabis care from consultation to delivery.

LYPHE GROUP is led by Chief Executive, Dean Friday, who brings over 12 years' experience as a senior executive driving growth in start-up businesses. Professor Mike Barnes also joins as both a board member and head of the Medical & Scientific Leadership Board as Chief Medical Officer. A consultant neurologist, trusted international medical cannabis expert and UK's leading medical campaigner for patient access, Professor Mike Barnes brings a wealth of unparalleled knowledge to LYPHE GROUP. They are joined by Jonathan Nadler, LYPHE GROUP's Chief Strategy Officer and Hannah Simon as Chief Operating Officer.

Hannah Deacon, tireless campaigner for UK access to medical cannabis for her young son Alfie Dingley and every patient in need, is Head of Patient Access. Hannah's involvement in LYPHE GROUP signals the company's unwavering commitment to place patient needs at the heart of everything it does.

Associate Professor of the Department of Agronomy at the University of Padova, Stefano Bona joins as LYPHE GROUP's Chief Scientific Officer after 30 years of research into the agricultural science of medical herbs, crops and soils. Andy Davies serves as Public Health Strategy Advisor with a focus on the UK market.

The company is headquartered in London, UK.

Dean Friday, CEO at LYPHE GROUP, commented:

"The launch of LYPHE GROUP is a pioneering step forward that will open up the market for import and prescribing of medical cannabis, improving access for patients in need. From training healthcare professionals to help them embrace this innovation in medicine, to providing the infrastructure for importation and fulfilling prescriptions, LYPHE GROUP supports the entire process – from consultation to delivery.

"Our integrated business model will help combat the disjointed system that currently inhibits patient access."

Hannah Deacon, Head of Patient Access at LYPHE GROUP, said:

"For many families like mine, medical cannabis is a lifeline and yet it continues to be exceptionally difficult for patients to gain access. LYPHE GROUP's all-encompassing service is a game-changer for the industry and I'm proud to be a part of an organisation committed to driving change so that more people in need have the opportunity to access medicines with the potential to give them a better quality of life."

Professor Mike Barnes, Chief Medical Officer at LYPHE GROUP, commented:

"The combined knowledge and expertise brought together under LYPHE GROUP is unparalleled. Our Medical & Scientific Leadership Board is comprised of world-leading clinicians and scientists and together with our educators, pharmacists and public policy experts, we are committed to opening up access and driving forward transformation in the industry for the benefit of patients."

Contact information

Please get in touch by emailing contact@lyphegroup.com for more information:

Images are available on request.

LYPHE GROUP was formerly the medical division of European Cannabis Holdings. ECH Ltd recently completed its demerger after successfully incubating what have become some of the world's leading cannabis companies.

Logo - https://mma.prnewswire.com/media/1007208/LYPHE_GROUP_Logo.jpg

Related Links

https://lyphegroup.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.